State of Wyoming Reduces Holdings in Acadia Healthcare Company, Inc. $ACHC

State of Wyoming lowered its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 35.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 29,982 shares of the company’s stock after selling 16,188 shares during the period. State of Wyoming’s holdings in Acadia Healthcare were worth $701,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. EverSource Wealth Advisors LLC boosted its position in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares during the period. Federated Hermes Inc. increased its position in Acadia Healthcare by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after buying an additional 668 shares during the period. Price T Rowe Associates Inc. MD increased its position in Acadia Healthcare by 0.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock worth $1,063,000 after buying an additional 696 shares during the period. Public Employees Retirement System of Ohio lifted its stake in Acadia Healthcare by 2.8% in the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after buying an additional 867 shares during the last quarter. Finally, Treasurer of the State of North Carolina boosted its holdings in shares of Acadia Healthcare by 2.1% in the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after acquiring an additional 867 shares during the period.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on ACHC shares. Cantor Fitzgerald raised their target price on shares of Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st. Barclays upped their price target on shares of Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Thursday, April 30th. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective on the stock in a research report on Monday, May 4th. UBS Group lifted their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday, July 9th. Finally, TD Cowen upped their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $28.69.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $34.01 on Friday. The stock has a market capitalization of $3.13 billion, a price-to-earnings ratio of -2.78, a PEG ratio of 11.60 and a beta of 0.64. The business’s 50 day moving average is $27.46 and its two-hundred day moving average is $23.10. Acadia Healthcare Company, Inc. has a 12-month low of $11.43 and a 12-month high of $35.83. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business had revenue of $828.80 million during the quarter, compared to analysts’ expectations of $823.51 million. During the same period last year, the firm earned $0.40 EPS. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Research analysts expect that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.